Alex Gorelik, CTO & Founder of Waterline Data
According to IDC, all the data that’s being created and captured in healthcare is projected to grow by 36 percent (CAGR)—more than any other industry.
While managing growing volumes of data is a common challenge for many organizations across all sectors, healthcare is uniquely set apart by the sheer number of new data sources that’s being made available—with new sources being added all the time. This is driven in large part by advancements in
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Report: Precision Medicine Is Impossible Without AI and Machine Learning
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals achieving the full potential of precision medicine is impossible to realize without applying AI and machine learning. Specifically, leveraging advanced machine learning and deep learning technology can rapidly analyze large datasets that outperform clinicians and researchers. Precision Medicine: Making
Read More
UIUC, Infosys Form Strategic Partnership to Develop Precision Medicine Solutions
The University of Illinois Urbana-Champaign (UIUC) and Infosys, a provider of next-generation digital services and consulting has formed a strategic partnership to develop precision medicine solutions. As part of the strategic partnership, Infosys becomes a member of the Center for Computational Biotechnology and Genomic Medicine (CCBGM). Precision Medicine Strategic Partnership DetailsThe adoption of precision medicine solutions by healthcare companies has significant benefits, including
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
Pittsburgh Health Data Alliance, Amazon Partner on Machine Learning Research Sponsorship
Pittsburgh Health Data Alliance (PHDA) announced today that it is working closely with Amazon Web Services (AWS), an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.Leveraging Machine Learning to Power Medical ResearchA unique consortium formed four years ago by UPMC, the University of Pittsburgh and Carnegie Mellon University (CMU), the PHDA uses
Read More
Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative
In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals
SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More
OSF Ventures Closes $75M Sophomore Venture Fund to Focus on Emerging Technologies
OSF Ventures, the corporate venture capital arm of Peoria, Ill.-based OSF HealthCare, has announced the closing of its sophomore venture capital fund of $75M. The sophomore fund will focus on investing in new technology, devices, and services that offer improved and more cost-efficient healthcare.Investment PhilosophyOSF focuses on investing in companies seeking funding at all post-seed stages and has invested primarily in Series A and B rounds. In addition, OSF Ventures is open to
Read More
Reducing Preventable Medication Errors and Adverse Drug Events
Dr. Chris Hobson, MD MBA, Chief Medical Officer at Orion Health
Using a Health Information Exchange (HIE), clinicians across multidisciplinary care teams can access a patient’s medications, reconcile the list and monitor their progress, thereby reducing medication errors and future costs from preventable hospital admissions.
Multiple factors combine to make the prescribing, supplying and taking of medications a perilous and costly issue for patients and the healthcare sector. Prescription
Read More
Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)
Syapse, a San Francisco, CA-based precision medicine company, today announced that it has entered into a strategic collaboration with Pfizer to advance cancer outcomes research using real-world evidence (RWE) toward the ultimate goal of improving patient health. This collaboration will initially focus on the molecular testing and therapy choices on precision oncology journeys in the healthcare system setting.Syapse NetworkThe Syapse Network enables health systems and their providers to learn
Read More
